ID

15114

Descripción

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet; ODM derived from: https://clinicaltrials.gov/show/NCT00118950

Link

https://clinicaltrials.gov/show/NCT00118950

Palabras clave

Versiones (1)
  1. 16/5/16 16/5/16 -
Subido en

16 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00118950

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT00118950

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type-2 diabetes, defined as:
Descripción

diabetes type 2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
age at onset of diabetes ≥ 40 years
Descripción

age at onset

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0332162
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
Descripción

serum c-peptide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006558
no history of ketonuria or ketoacidosis .
Descripción

ketonuria or ketoacidosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0162275
UMLS CUI [1,2]
C0011880
bmi ≤ 27 kg/m2.
Descripción

bmi

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
Descripción

plasma-glucose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202042
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
Descripción

hba1c

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
Descripción

weight-loss

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0439792
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
type-1 diabetes
Descripción

diabetes type 1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
insulin-treated type-2 diabetes
Descripción

diabetes type

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
UMLS CUI [1,3]
C0745343
secondary diabetes, heart-failure
Descripción

diabetes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0277555
UMLS CUI [1,3]
C0018801
serum-creatinine above the upper limit
Descripción

creatinine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
serum-asat elevated more than 3 fold above the upper limit
Descripción

asat

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
factor ii-vii-x decreased below 0.7
Descripción

blood coagulating factor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005789
UMLS CUI [1,2]
C0547047
ongoing coexisting illnesses with a life-shortening prognosis
Descripción

life shortening comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0023671
mental retardation or reduced intellectual behaviour
Descripción

mental retardation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025362
pregnancy
Descripción

pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
Descripción

drug-abuse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0019018
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00118950

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
diabetes type 2
Item
type-2 diabetes, defined as:
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
age at onset
Item
age at onset of diabetes ≥ 40 years
boolean
C0001779 (UMLS CUI [1,1])
C0332162 (UMLS CUI [1,2])
serum c-peptide
Item
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
boolean
C0006558 (UMLS CUI [1])
ketonuria or ketoacidosis
Item
no history of ketonuria or ketoacidosis .
boolean
C0162275 (UMLS CUI [1,1])
C0011880 (UMLS CUI [1,2])
bmi
Item
bmi ≤ 27 kg/m2.
boolean
C1305855 (UMLS CUI [1])
plasma-glucose
Item
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
boolean
C0202042 (UMLS CUI [1])
hba1c
Item
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
boolean
C0019018 (UMLS CUI [1])
weight-loss
Item
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
boolean
C1262477 (UMLS CUI [1,1])
C0439792 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
diabetes type 1
Item
type-1 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
diabetes type
Item
insulin-treated type-2 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0745343 (UMLS CUI [1,3])
diabetes
Item
secondary diabetes, heart-failure
boolean
C0011849 (UMLS CUI [1,1])
C0277555 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
creatinine
Item
serum-creatinine above the upper limit
boolean
C0201976 (UMLS CUI [1])
asat
Item
serum-asat elevated more than 3 fold above the upper limit
boolean
C0201899 (UMLS CUI [1])
blood coagulating factor
Item
factor ii-vii-x decreased below 0.7
boolean
C0005789 (UMLS CUI [1,1])
C0547047 (UMLS CUI [1,2])
life shortening comorbidity
Item
ongoing coexisting illnesses with a life-shortening prognosis
boolean
C0009488 (UMLS CUI [1,1])
C0023671 (UMLS CUI [1,2])
mental retardation
Item
mental retardation or reduced intellectual behaviour
boolean
C0025362 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
drug-abuse
Item
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
boolean
C0013146 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial